Affordable Access

[Proportion and significance of CD1d(hi)CD5⁺CD19⁺ regulatory B cell in peripheral blood of patients with neuromyelitis optica].

Authors
  • Yang, Fen1
  • Huang, Dehui2
  • Cheng, Chen1
  • Wu, Weiping1
  • 1 Department of Neurology in South Building, General Hospital of PLA, Beijing 100853, China. , (China)
  • 2 Department of Neurology, General Hospital of PLA, Beijing 100853, China. , (China)
Type
Published Article
Journal
Xi bao yu fen zi mian yi xue za zhi = Chinese journal of cellular and molecular immunology
Publication Date
Mar 01, 2015
Volume
31
Issue
3
Pages
375–378
Identifiers
PMID: 25744844
Source
Medline
License
Unknown

Abstract

CD1d(hi)CD5⁺CD19⁺ Bregs may be a biomarker in the differential diagnosis of NMO versus MS.

Report this publication

Statistics

Seen <100 times